394 related articles for article (PubMed ID: 20586863)
1. Protective effect of roxatidine against indomethacin-induced small intestinal mucosal injury in rats.
Umegaki E; Yoda Y; Tokioka S; Murano M; Higuchi K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S35-40. PubMed ID: 20586863
[TBL] [Abstract][Full Text] [Related]
2. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
Tanaka A; Mizoguchi H; Hase S; Miyazawa T; Takeuchi K
Med Sci Monit; 2001; 7(5):869-77. PubMed ID: 11535926
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
Amagase K; Ochi A; Sugihara T; Kato S; Takeuchi K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S111-8. PubMed ID: 20586851
[TBL] [Abstract][Full Text] [Related]
4. A histamine H2 receptor antagonist, roxatidine, stimulates mucus secretion and synthesis by cultured rabbit gastric mucosal cells.
Takahashi S; Okabe S
J Physiol Pharmacol; 1995 Dec; 46(4):503-11. PubMed ID: 8770793
[TBL] [Abstract][Full Text] [Related]
5. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.
Satoh H; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201
[TBL] [Abstract][Full Text] [Related]
6. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
7. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats.
Tanaka A; Kunikata T; Mizoguchi H; Kato S; Takeuchi K
J Physiol Pharmacol; 1999 Sep; 50(3):405-17. PubMed ID: 10574470
[TBL] [Abstract][Full Text] [Related]
8. Gastroprotective effect of simvastatin against indomethacin-induced gastric ulcer in rats: role of nitric oxide and prostaglandins.
Heeba GH; Hassan MK; Amin RS
Eur J Pharmacol; 2009 Apr; 607(1-3):188-93. PubMed ID: 19217901
[TBL] [Abstract][Full Text] [Related]
9. Structural requirements for roxatidine in the stimulant effect of rat gastric mucin synthesis and the participation of nitric oxide in this mechanism.
Ichikawa T; Ishihara K; Saigenji K; Hotta K
Br J Pharmacol; 1997 Nov; 122(6):1230-6. PubMed ID: 9401791
[TBL] [Abstract][Full Text] [Related]
10. Cytoprotective action of roxatidine acetate HCl.
Shiratsuchi K; Fuse H; Hagiwara M; Mikami T; Miyasaka K; Sakuma H
Arch Int Pharmacodyn Ther; 1988; 294():295-304. PubMed ID: 2906796
[TBL] [Abstract][Full Text] [Related]
11. Effect of pibutidine hydrochloride on nitric oxide production in rat gastric mucosa.
Kiuchi Y; Isobe Y; Kijima H; Higuchi S; Fukushima K
Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):273-82. PubMed ID: 9730007
[TBL] [Abstract][Full Text] [Related]
12. Endogenous prostaglandin E2 accelerates healing of indomethacin-induced small intestinal lesions through upregulation of vascular endothelial growth factor expression by activation of EP4 receptors.
Takeuchi K; Tanigami M; Amagase K; Ochi A; Okuda S; Hatazawa R
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S67-74. PubMed ID: 20586869
[TBL] [Abstract][Full Text] [Related]
13. New method of inducing intestinal lesions in rats by intraduodenal administration of aspirin.
Nonoyama K; Nakagawa K; Amagase K; Takeuchi K; Nakamura M; Okabe S
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S15-22. PubMed ID: 20586859
[TBL] [Abstract][Full Text] [Related]
14. Role of endogenous nitric oxide (NO) and NO synthases in healing of indomethacin-induced intestinal ulcers in rats.
Takeuchi K; Hatazawa R; Tanigami M; Tanaka A; Ohno R; Yokota A
Life Sci; 2007 Jan; 80(4):329-36. PubMed ID: 17045617
[TBL] [Abstract][Full Text] [Related]
15. Protection by constitutively formed nitric oxide of intestinal damage induced by indomethacin in rats.
Tanaka A; Mizoguchi H; Kunikata T; Miyazawa T; Takeuchi K
J Physiol Paris; 2001; 95(1-6):35-41. PubMed ID: 11595416
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats.
Konaka A; Nishijima M; Tanaka A; Kunikata T; Kato S; Takeuchi K
J Physiol Pharmacol; 1999 Mar; 50(1):25-38. PubMed ID: 10210152
[TBL] [Abstract][Full Text] [Related]
17. Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric-oxide synthase inhibitors.
Ohno R; Yokota A; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2004 Aug; 310(2):821-7. PubMed ID: 15044560
[TBL] [Abstract][Full Text] [Related]
18. Investigation on the mechanisms involved in the central protective effect of amylin on gastric ulcers in rats.
Guidobono F; Pagani F; Ticozzi C; Sibilia V; Netti C
Br J Pharmacol; 1998 Sep; 125(1):23-8. PubMed ID: 9776339
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons.
Kato S; Tanaka A; Kunikata T; Umeda M; Takeuchi K
Digestion; 2000; 61(1):39-46. PubMed ID: 10671773
[TBL] [Abstract][Full Text] [Related]
20. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
Sekiguchi H; Hamada K; Aijima H; Taga F; Uchida H; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):139-43. PubMed ID: 8096134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
